Literature DB >> 6192303

Oncogenes.

P Hamlyn, K Sikora.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6192303     DOI: 10.1016/s0140-6736(83)90300-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  The development of new radiopharmaceuticals.

Authors:  K E Britton
Journal:  Eur J Nucl Med       Date:  1990

Review 2.  Free radical involvement in aging. Pathophysiology and therapeutic implications.

Authors:  D Harman
Journal:  Drugs Aging       Date:  1993 Jan-Feb       Impact factor: 3.923

3.  Biotechnology in medicine.

Authors:  A M Green
Journal:  Can Med Assoc J       Date:  1984-03-01       Impact factor: 8.262

Review 4.  An appraisal of the application of recombinant DNA techniques to chromosome defects.

Authors:  K P Ellis; K E Davies
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

5.  Oncogenes and human cancer--a surgeon's perspective.

Authors:  N I Markham
Journal:  Ann R Coll Surg Engl       Date:  1985-09       Impact factor: 1.891

6.  c-myc oncogene product expression and prognosis in operable breast cancer.

Authors:  A P Locker; C S Dowle; I O Ellis; C W Elston; R W Blamey; K Sikora; G Evan; R A Robins
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

7.  Detection of the c-myc oncogene product in testicular cancer.

Authors:  K Sikora; G Evan; J Stewart; J V Watson
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

8.  The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer.

Authors:  J V Watson; J Stewart; G I Evan; A Ritson; K Sikora
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

9.  Detection of the c-myc oncogene product in colonic polyps and carcinomas.

Authors:  J Stewart; G Evan; J Watson; K Sikora
Journal:  Br J Cancer       Date:  1986-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.